RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 169 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.48 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $141,516,534 | -0.1% | 3,446,579 | +5.4% | 3.41% | +37.6% |
| Q1 2024 | $141,627,528 | +43.0% | 3,268,579 | +51.7% | 2.48% | +12.1% |
| Q4 2023 | $99,024,437 | +1034.2% | 2,154,110 | +465.6% | 2.21% | +659.5% |
| Q3 2023 | $8,730,482 | +235.8% | 380,828 | +122.9% | 0.29% | +327.9% |
| Q1 2020 | $2,600,000 | -33.7% | 170,859 | 0.0% | 0.07% | -12.8% |
| Q4 2019 | $3,922,000 | -32.2% | 170,859 | -35.0% | 0.08% | -41.4% |
| Q2 2019 | $5,785,000 | -58.0% | 262,970 | -47.7% | 0.13% | -65.8% |
| Q1 2019 | $13,786,000 | +0.2% | 502,970 | -1.2% | 0.39% | -25.8% |
| Q4 2018 | $13,763,000 | -29.0% | 509,186 | -23.3% | 0.52% | +1.2% |
| Q3 2018 | $19,374,000 | -22.6% | 664,186 | -17.0% | 0.52% | -21.0% |
| Q2 2018 | $25,029,000 | +112.4% | 800,686 | +35.2% | 0.66% | +98.8% |
| Q1 2018 | $11,786,000 | -45.6% | 592,286 | -20.5% | 0.33% | -54.0% |
| Q4 2017 | $21,654,000 | – | 745,135 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,909,258 | $41,374,000 | 7.72% |
| NEA Management Company, LLC | 4,912,306 | $106,450,000 | 4.51% |
| RA Capital Management | 5,140,408 | $111,393,000 | 2.04% |
| Samsara BioCapital, LLC | 234,846 | $5,089,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,897,047 | $41,109,000 | 1.00% |
| Rock Springs Capital Management LP | 464,086 | $10,057,000 | 0.26% |
| Baker Brothers Advisors | 2,471,155 | $53,550,000 | 0.21% |
| Virtus ETF Advisers LLC | 15,384 | $333,000 | 0.18% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 423 | $9,000 | 0.17% |
| PRW Wealth Management LLC | 9,600 | $208,000 | 0.15% |